A
Apontis Pharma AG
XETRA:APPH
Apontis Pharma AG
XETRA:APPH
Price:
11.25
EUR
2.27%
Market Closed
Market Cap:
95.6m
EUR
P/E
Price to Earnings
Price to Earnings
-14.2
Current
-3.5
Median
20.5
Industry
Lower
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=-14.2
Market Cap
/
93.7m EUR
Net Income
-6.6m EUR
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
94.8
2-Years Forward
P/E
26.4
3-Years Forward
P/E
14.3
You don't have any saved screeners yet
